Spoken approach
say this aloud Free preview- When I see a patient with proteinuric CKD, my first step is to assess their eligibility for foundational therapies based on the latest evidence.
- I'll start with RAAS inhibition (losartan/irbesartan) as per RENAAL/IDNT, ensuring the patient is on a maximally tolerated dose.
- Next, I'll add an SGLT2 inhibitor like dapagliflozin or empagliflozin, referencing DAPA-CKD and EMPA-KIDNEY, which showed benefit in patients with and without diabetes.
+ 8 more steps of the spoken answer for subscribers